Barclays analyst Michael Leithead lowered the firm’s price target on Dow Inc. to $56 from $60 and keeps an Equal Weight rating on the shares. Demand “remains tepid” for U.S. chemicals into the Q2 prints and hopes for a second half of the year recovery “have dimmed,” the analyst tells investors in a research note. While demand “seems to be at trough,” the firm does not think earnings revisions “are quite there yet.” Barclays is not in the camp to “buy the last cut” and continues to pick its spots, with tactical caution across the space into earnings.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DOW:
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Dow Inc. downgraded to Underperform at BofA on commodity chemical caution
- Dow Inc. downgraded to Underperform from Neutral at BofA
- Dow Chemical call volume above normal and directionally bullish
- Citi starts coverage of North America Chemicals with 7 Buys, 8 Neutrals